CONTROLLED RELEASE DOSAGE FORMS
The invention provides stable controlled release monolithic coating compositions for use in coating pharmaceutical oral dosage forms comprising a polyglycol having a melting point greater than 55° C. and an aqueous dispersion of a neutral ester copolymer lacking functional groups.
1 . A stable controlled release monolithic coating composition for use in coating a pharmaceutical oral dosage form, said coating comprising:
a) an aqueous dispersion of a neutral ester copolymer without any functional groups;
b) a poly glycol having a melting point greater than 55° C., and
c) one or more pharmaceutically acceptable excipients; wherein said coating composition is coated onto said pharmaceutical oral dosage form and cured at a temperature at least equal to or greater than the melting point of said poly glycol.
2 - 40 . (canceled)